(Q35879714)

10 August 2017

1 reference

title

Management of severe COPD. (English)

1 reference

10 August 2017

E F M Wouters

1

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 September 2004

1 reference

10 August 2017

1 reference

10 August 2017

volume

364

1 reference

10 August 2017

issue

9437

1 reference

10 August 2017

page(s)

883-895

1 reference

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Pulmonary rehabilitation in chronic respiratory insufficiency. 7. Health-related quality of life among patients with chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Prognostic Value of Nutritional Status in Chronic Obstructive Pulmonary Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Analysis of the factors related to mortality in chronic obstructive pulmonary disease: role of exercise capacity and health status.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Use of factor analysis to consolidate multiple outcome measures in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Factor analysis of exercise capacity, dyspnoea ratings and lung function in patients with severe COPD.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

A Factor Analysis of Dyspnea Ratings, Respiratory Muscle Strength, and Lung Function in Patients with Chronic Obstructive Pulmonary Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

The assessment of health status among patients with COPD.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

How well do we care for patients with end stage chronic obstructive pulmonary disease (COPD)? A comparison of palliative care and quality of life in COPD and lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

The psychological impact of end-stage lung disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Patients' perspectives on physician skill in end-of-life care: differences between patients with COPD, cancer, and AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Understanding the Treatment Preferences of Seriously Ill Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Efficacy of inhaled salmeterol in the management of smokers with chronic obstructive pulmonary disease: a single centre randomised, double blind, placebo controlled, crossover study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Quality of life changes in COPD patients treated with salmeterol

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Efficacy of salmeterol xinafoate in the treatment of COPD

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Use of a long-acting inhaled beta2-adrenergic agonist, salmeterol xinafoate, in patients with chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

A 6-month, placebo-controlled study comparing lung function and health status changes in COPD patients treated with tiotropium or salmeterol

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Dynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

A randomized, controlled trial of theophylline in patients with severe chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Value of theophylline treatment in patients handicapped by chronic obstructive lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Theophylline improves gas exchange during rest, exercise, and sleep in severe chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Effects of theophylline on diaphragmatic strength and fatigue in patients with chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Response to oral theophylline in severe chronic obstructive airways disease: Authors' reply

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

In chronic obstructive pulmonary disease, a combination of ipratropium and albuterol is more effective than either agent alone. An 85-day multicenter trial. COMBIVENT Inhalation Aerosol Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

A long-term prospective assessment of home nebulizer treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Results of a multicenter study of nebulized inhalant bronchodilator solutions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Steroid reversibility test followed by inhaled budesonide or placebo in outpatients with stable chronic obstructive pulmonary disease. The Danish Society of Respiratory Medicine.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Withdrawal of chronic systemic corticosteroids in patients with COPD: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Corticosteroids contribute to muscle weakness in chronic airflow obstruction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Corticosteroid-induced myopathy involving respiratory muscles in patients with chronic obstructive pulmonary disease or asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Dose response relation to oral theophylline in severe chronic obstructive airways disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Efficacy of pneumococcal vaccine in high-risk patients. Results of a Veterans Administration Cooperative Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Pneumococcal vaccine and patients with chronic lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Pneumococcal infection and immunologic response to pneumococcal vaccine in chronic obstructive pulmonary disease. A pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Current and future medical costs of asthma and chronic obstructive pulmonary disease in The Netherlands

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Impact of COPD in North America and Europe in 2000: subjects' perspective of Confronting COPD International Survey

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Economic analysis of the Confronting COPD survey: an overview of results

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease. International COPD Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Toward a consensus definition for COPD exacerbations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Infective exacerbations of chronic bronchitis: relation between bacteriologic etiology and lung function

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Relationship Between Bacterial Flora in Sputum and Functional Impairment in Patients With Acute Exacerbations of COPD

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Bacterial infections in patients requiring admission for an acute exacerbation of COPD; a 1-year prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Infectious etiology of acute exacerbations of chronic bronchitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Oropharyngeal gram-negative bacillary carriage in chronic obstructive pulmonary disease: relation to severity of disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Simultaneous Respiratory Tract Colonization by Multiple Strains of NontypeableHaemophilus influenzaein Chronic Obstructive Pulmonary Disease: Implications for Antibiotic Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

New strains of bacteria and exacerbations of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Management of acute exacerbations of chronic obstructive pulmonary disease: a summary and appraisal of published evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Detection of rhinovirus in induced sputum at exacerbation of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Air pollution and daily admissions for chronic obstructive pulmonary disease in six European cities: results from the APHEA project. Air Pollution and Health, a European Approach

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Air pollution and daily admissions for chronic obstructive pulmonary disease in 6 European cities: results from the APHEA project

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Short term variations in hospital admissions and mortality and particulate air pollution

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Fine particulate air pollution and mortality in 20 U.S. cities, 1987-1994

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Effects of an immunostimulating agent on acute exacerbations and hospitalizations in patients with chronic obstructive pulmonary disease. The PARI-IS Study Steering Committee and Research Group. Prevention of Acute Respiratory Infection by an Immuno

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Quality of life and hospital re-admission in patients with chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Muscle weakness is related to utilization of health care resources in COPD patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Risk factors for hospitalization for a chronic obstructive pulmonary disease exacerbation. EFRAM study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Comparison of nebulized budesonide and oral prednisolone with placebo in the treatment of acute exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Effect of viral infections on pulmonary function in patients with chronic obstructive pulmonary diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Controlled trial of oral prednisone in outpatients with acute COPD exacerbation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Effects of an acute exacerbation on nutritional and metabolic profile of patients with COPD

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Systemic anti-inflammatory mediators in COPD: increase in soluble interleukin 1 receptor II during treatment of exacerbations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Mechanisms of worsening gas exchange during acute exacerbations of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Outpatient oral prednisone after emergency treatment of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

The role of hypoventilation and ventilation-perfusion redistribution in oxygen-induced hypercapnia during acute exacerbations of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Acute exacerbations in patients with COPD: predictors of need for mechanical ventilation.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Hyponatremia and increased exchangeable sodium in chronic obstructive lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Pathogenesis of congestive state in chronic obstructive pulmonary disease. Studies of body water and sodium, renal function, hemodynamics, and plasma hormones during edema and after recovery

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Abnormalities of sodium and H2O handling in chronic obstructive lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Hormonal abnormalities affecting sodium and water balance in acute respiratory failure due to chronic obstructive lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Changes in atrial natriuretic peptide concentrations during intravenous saline infusion in hypoxic cor pulmonale

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

The effect of oxygen on sodium excretion in hypoxemic patients with chronic obstructive lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Oxygen administration increases plasma digoxin-like substance and renal sodium excretion in chronic hypoxic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Renal and hormonal abnormalities in chronic obstructive pulmonary disease (COPD).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Short term effect of oxygen on renal haemodynamics in patients with hypoxaemic chronic obstructive airways disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

The acute effects of oxygen and carbon dioxide on renal vascular resistance in patients with an acute exacerbation of COPD

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Effect of L-arginine on renal blood flow in normal subjects and patients with hypoxic chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Renal functional reserve in patients with severe chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Studies on the mechanism of hypernatriuresis in essential hypertension in relation to measurements of plasma renin concentration, body fluid compartments and renal function

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Impact of hypoxaemia on neuroendocrine function and catecholamine secretion in chronic obstructive pulmonary disease (COPD). Effects of long-term oxygen treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Kidney function in cor pulmonale; particular consideration of changes in renal hemodynamics and sodium excretion during variation in level of oxygenation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Atrial natriuretic peptide, renin and aldosterone in obstructive lung disease and heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Plasma levels of atrial natriuretic factor, renin activity, and aldosterone in patients with chronic obstructive pulmonary disease. Response to O2 removal and to hyperoxia.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Oedema and cor pulmonale revisited

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Atrial natriuretic peptide concentrations in hypoxic secondary pulmonary hypertension: relation to haemodynamic and blood gas variables and response to supplemental oxygen

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Pathophysiology of cor pulmonale in chronic obstructive pulmonary disease. Part One.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Fluid homeostasis in chronic obstructive lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Effect of carbon dioxide on diaphragmatic function in human beings

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Non-invasive ventilation for acute exacerbations of COPD: a new standard of care

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Chronic obstructive pulmonary disease * 9: management of ventilatory failure in COPD

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Respiratory stimulation with intravenous doxapram in respiratory failure. A double-blind co-operative study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Randomised controlled trial of nasal ventilation in acute ventilatory failure due to chronic obstructive airways disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Comparison of noninvasive positive pressure ventilation with standard medical therapy in hypercapnic acute respiratory failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Early use of non-invasive ventilation for acute exacerbations of chronic obstructive pulmonary disease on general respiratory wards: a multicentre randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Noninvasive ventilatory support does not facilitate recovery from acute respiratory failure in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Randomized, prospective trial of noninvasive positive pressure ventilation in acute respiratory failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Non-invasive positive pressure ventilation to treat respiratory failure resulting from exacerbations of chronic obstructive pulmonary disease: Cochrane systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Cost effectiveness of ward based non-invasive ventilation for acute exacerbations of chronic obstructive pulmonary disease: economic analysis of randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Non-invasive ventilation in acute exacerbations of chronic obstructive pulmonary disease: long term survival and predictors of in-hospital outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Nocturnal Oxygen Therapy Trial Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Effect of long-term oxygen therapy on survival in patients with chronic obstructive pulmonary disease with moderate hypoxaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Comparison of the efficacy of a demand oxygen delivery system with continuous low flow oxygen in subjects with stable COPD and severe oxygen desaturation on walking

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Oxygen supplementation before or after submaximal exercise in patients with chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Ambulatory oxygen improves quality of life of COPD patients: a randomised controlled study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Nutritional depletion in relation to respiratory and peripheral skeletal muscle function in out-patients with COPD

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Nutritional status of patients with chronic obstructive pulmonary disease and acute respiratory failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Nutritional abnormalities and supplementation in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Characterization of nonresponse to high caloric oral nutritional therapy in depleted patients with chronic obstructive pulmonary disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Elevated TNF-alpha production by peripheral blood monocytes of weight-losing COPD patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Tumor necrosis factor-alpha levels and weight loss in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Plasma leptin is related to proinflammatory status and dietary intake in patients with chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Circulating leptin in patients with chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Mechanisms of muscle wasting. The role of the ubiquitin-proteasome pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

What do we really know about the ubiquitin-proteasome pathway in muscle atrophy?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Skeletal muscle myocytes undergo protein loss and reactive oxygen-mediated NF-kappaB activation in response to tumor necrosis factor alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Inflammatory cytokines inhibit myogenic differentiation through activation of nuclear factor-kappaB.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Skeletal muscle apoptosis and weight loss in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Signalling pathways that mediate skeletal muscle hypertrophy and atrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Body composition by bioelectrical-impedance analysis compared with deuterium dilution and skinfold anthropometry in patients with chronic obstructive pulmonary disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Dual-energy X-ray absorptiometry in the clinical evaluation of body composition and bone mineral density in patients with chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Nutritional status and mortality in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Body weight in chronic obstructive pulmonary disease. The National Institutes of Health Intermittent Positive-Pressure Breathing Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Prognostic value of nutritional depletion in patients with COPD treated by long-term oxygen therapy: data from the ANTADIR observatory

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Peak exercise response in relation to tissue depletion in patients with chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Skeletal muscle weakness is associated with wasting of extremity fat-free mass but not with airflow obstruction in patients with chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Nutritional state and exercise tolerance in patients with COPD

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Effect of reduced body weight on muscle aerobic capacity in patients with COPD.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Body composition and health-related quality of life in patients with obstructive airways disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Early non-elective readmission for chronic obstructive pulmonary disease is associated with weight loss

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Prevalence and consequences of nutritional depletion in lung transplant candidates

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

The impact of nutritional status on the outcome of lung volume reduction surgery: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Dietary change, nutrition education and chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Nutritional support for individuals with COPD: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Physiologic effects of nutritional support and anabolic steroids in patients with chronic obstructive pulmonary disease. A placebo-controlled randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Efficacy of nutritional supplementation therapy in depleted patients with chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Pulmonary rehabilitation research

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Randomised controlled trial of respiratory rehabilitation.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Effects of pulmonary rehabilitation on physiologic and psychosocial outcomes in patients with chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Short- and long-term effects of outpatient rehabilitation in patients with chronic obstructive pulmonary disease: a randomized trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Long-term effectiveness of pulmonary rehabilitation in patients with chronic airway obstruction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Cost effectiveness of an outpatient multidisciplinary pulmonary rehabilitation programme

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Reductions in exercise lactic acidosis and ventilation as a result of exercise training in patients with obstructive lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Oxidative capacity of the skeletal muscle and lactic acid kinetics during exercise in normal subjects and in patients with COPD

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Intensity of training and physiologic adaptation in patients with chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Skeletal muscle strength and endurance in patients with mild COPD and the effects of weight training

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Guidance Concerning Surgery for Emphysema

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Heart-lung transplantation: successful therapy for patients with pulmonary vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

The history of surgical procedures for emphysema

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Short-term and Long-term Outcomes After Bilateral Lung Volume Reduction Surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Effect of lung-volume-reduction surgery in patients with severe emphysema.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Improvement in Pulmonary Function and Elastic Recoil after Lung-Reduction Surgery for Diffuse Emphysema

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Lung function 4 years after lung volume reduction surgery for emphysema

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Reduction pneumoplasty versus respiratory rehabilitation in severe emphysema: a randomized study. Pulmonary Emphysema Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Rationale and design of the national emphysema treatment trial (NETT): A prospective randomized trial of lung volume reduction surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Economic analysis of lung volume reduction surgery as part of the National Emphysema Treatment Trial. NETT Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Chronic obstructive pulmonary disease. 10: Bullectomy, lung volume reduction surgery, and transplantation for patients with chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Bronchoscopic volume reduction with valve implants in patients with severe emphysema

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Patients at high risk of death after lung-volume-reduction surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

Cost effectiveness of lung-volume-reduction surgery for patients with severe emphysema

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

The Registry of the International Society for Heart and Lung Transplantation: eighteenth Official Report-2001.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916984-5

7 January 2021

10.1016/S0140-6736(04)16984-5

Identifiers

DOI

1 reference

10 August 2017

1 reference